Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes
Aitana Sogorb‐Esteve(UK Dementia Research Institute), Stefano Gazzina(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Emily Todd(UK Dementia Research Institute), Caroline Graff(Karolinska Institutet), Joel Simrén(University of Gothenburg), Maria Carmela Tartaglia, Enrico Premi(Anna Needs Neuroblastoma Answers), James B. Rowe(MRC Cognition and Brain Sciences Unit), Timothy Rittman(Addenbrooke's Hospital), Kaj Blennow(Sahlgrenska University Hospital), Alexander Gerhard(University of Manchester), Christopher Butler(Pontificia Universidad Católica de Chile), Roberto Gasparotti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Matthis Synofzik(German Center for Neurodegenerative Diseases), Imogen J. Swift(UK Dementia Research Institute), Johannes Levin(The University of Melbourne), Sophia Weiner(Institute of Neurobiology), Alexandre de Mendonça(University of Lisbon), Eve Ferry‐Bolder(UK Dementia Research Institute), David M. Cash(UK Dementia Research Institute), Thomas Cope(National Health and Medical Research Council), Raquel Sánchez‐Valle(Biomedical Research Networking Center on Neurodegenerative Diseases), Harro Seelaar(Erasmus MC), Pietro Tiraboschi(Mayo Clinic in Florida), Phoebe H. Foster(UK Dementia Research Institute), Arabella Bouzigues(UK Dementia Research Institute), Alberto Benussi(University of Trieste), Isabel Santana(Hospitais da Universidade de Coimbra), Lize C. Jiskoot(Erasmus MC), Martina Bocchetta(UK Dementia Research Institute), Lucy L. Russell(UK Dementia Research Institute), Jonathan D. Rohrer(University Memory and Aging Center), Markus Otto(University Hospital in Halle), Rik Vandenberghe(Allen Institute for Brain Science), Elizabeth Finger(Western University), Henrik Zetterberg(University of Wisconsin–Madison), Daniela Galimberti(University of Milan), Mario Masellis(Sunnybrook Health Science Centre), Fermín Moreno(Instituto de Salud Carlos III), David L. Thomas(University College London), Rhian S. Convery, Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Robert Laforce(Université Laval), Simon Ducharme(Montreal Neurological Institute and Hospital), Silvana Archetti(University of Brescia), Isabelle Le Ber(Centre National de la Recherche Scientifique), John C. van Swieten(Erasmus MC), Johan Gobom(Sahlgrenska University Hospital), Florence Pasquier(Inserm), Sandro Sorbi(University of Florence)
Cited by 13
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k